Recent blog posts
Potential treatment drugs for autoimmune diseases - IL-17 inhibitors
Potential treatment drugs for autoimmune diseases - IL-17 inhibitors
22 September 2023
IL-17, or Interleukin-17, is a cytokine that plays a crucial role in the human body's immune response.
Read →
Precise Therapy for Leukemia – IDH1 Inhibitors
Precise Therapy for Leukemia – IDH1 Inhibitors
22 September 2023
IDH includes three subtypes -IDH1, IDH2, and IDH3. Depending on the subtype, they can be monomers, homodimers, and polymers.
Read →
Analysis on the Research Progress of HIV-1 Protease Inhibitors
Analysis on the Research Progress of HIV-1 Protease Inhibitors
22 September 2023
HIV-1 protease is an enzyme that plays a crucial role in the replication of the human immunodeficiency virus (HIV-1) within the human body.
Read →
Analysis on the Research Progress of GnRHR antagonists
Analysis on the Research Progress of GnRHR antagonists
22 September 2023
GnRH, also known as Gonadotropin-Releasing Hormone, is a decapeptide hormone secreted by the arcuate nucleus neurons in the hypothalamus.
Read →
Analysis on the Research Progress of HSP90 inhibitors
Analysis on the Research Progress of HSP90 inhibitors
21 September 2023
Heat shock protein 90 (HSP90) is an ATP-dependent molecular chaperone essential in eukaryotic organisms.
Read →
The Clinical Application of Histamine Receptor Antagonists
The Clinical Application of Histamine Receptor Antagonists
21 September 2023
Histamine receptors are proteins found in various tissues throughout the human body.
Read →
Progress in the Research of Heparin antagonists
Progress in the Research of Heparin antagonists
21 September 2023
Heparin is a naturally occurring anticoagulant that plays a crucial role in the human body's blood clotting process.
Read →
Analysis on the Clinical Research Progress of CTLA-4 Inhibitors
Analysis on the Clinical Research Progress of CTLA-4 Inhibitors
21 September 2023
Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4), also known as CD152, is a transmembrane protein on the surface of T cells encoded by the CTLA-4 gene.
Read →
Review and Prospects of CYP1A2 Inhibitors
Review and Prospects of CYP1A2 Inhibitors
21 September 2023
Recombinant Cytochrome P450 1A2 (CYP1A2) belongs to the CYP1A subfamily of the CYP1 family and is encoded by the CYP1A2 gene.
Read →
Progress in Clinical Research of HDAC6 Inhibitors
Progress in Clinical Research of HDAC6 Inhibitors
20 September 2023
HDAC6 is the largest member of the HDAC family, consisting of 1215 amino acids.
Read →
Progress in the Study of HIV-1 Integrase Inhibitors
Progress in the Study of HIV-1 Integrase Inhibitors
20 September 2023
HIV-1 integrase is an enzyme that plays a crucial role in the replication of the human immunodeficiency virus (HIV-1) within the human body.
Read →
Advances in the Application of HER2 Inhibitors in Tumors
Advances in the Application of HER2 Inhibitors in Tumors
20 September 2023
Human Epidermal Growth Factor Receptor 2 (HER2) is a member of the EGFR kinase family, which also includes HER1, HER3, and HER4.
Read →